Dingding Deng
Biographic Data
| ID | 9018068 |
|---|---|
| NAME | Dingding Deng |
| GIVEN NAMES | Dingding |
| FAMILY NAME | Deng |
| SIGNATURE | DENG D |
| AFFILIATIONS | Shaoyang University |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
The treatment responses among different inhalation therapies for Gold group E patients with chronic obstructive pulmonary disease
Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 revised the combined chronic obstructive pulmonary disease (COPD) assessment, merging groups C and D into group E, and revised the initial inhalation therapy recommendation. We aimed to evaluate the treatment responses among different inhalation therapies in GOLD group E patients stratified by the COPD assessment test (CAT) scores and forced expiratory volume in on…
Application of Gold 2023 Initial Inhalation Therapy Recommendations in COPD patients
Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report revised the combined chronic obstructive pulmonary disease (COPD) assessment. Patients were classified into groups A, B, and E, and the initial inhalation therapy recommendations were revised. This study aimed to investigate the application status of initial inhalation therapy recommendations in patients with COPD and determine whether adherence to the GOLD …
Clinical characteristics and all-cause mortality in female patients with idiopathic pulmonary fibrosis in Chinese population
Background: Idiopathic pulmonary fibrosis (IPF) exhibits notable sex-based disparities and male patients with IPF are significantly more numerous than female patients. Therefore, the female patients are often overlooked and under-investigated. This study aimed to evaluate the clinical characteristics and all-cause mortality in female patients with IPF in Chinese population. Methods: /VA), laboratory analysis, comorbidities, and antifibrotic thera…
Development and validation of a nomogram model for mortality prediction in stable chronic obstructive pulmonary disease patients
Background: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. There is no nomogram model available for mortality prediction of stable COPD. We intended to develop and validate a nomogram model to predict mortality risk in stable COPD patients for personalised prognostic assessment. Methods: A prospective observational study was made of COPD outpatients registered in the RealDTC study between December 2016…
No prominent works on this page.
Development and validation of a nomogram model for mortality prediction in stable chronic obstructive pulmonary disease patients
Background: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. There is no nomogram model available for mortality prediction of stable COPD. We intended to develop and validate a nomogram model to predict mortality risk in stable COPD patients for personalised prognostic assessment. Methods: A prospective observational study was made of COPD outpatients registered in the RealDTC study between December 2016…
The treatment responses among different inhalation therapies for Gold group E patients with chronic obstructive pulmonary disease
Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 revised the combined chronic obstructive pulmonary disease (COPD) assessment, merging groups C and D into group E, and revised the initial inhalation therapy recommendation. We aimed to evaluate the treatment responses among different inhalation therapies in GOLD group E patients stratified by the COPD assessment test (CAT) scores and forced expiratory volume in on…
Application of Gold 2023 Initial Inhalation Therapy Recommendations in COPD patients
Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report revised the combined chronic obstructive pulmonary disease (COPD) assessment. Patients were classified into groups A, B, and E, and the initial inhalation therapy recommendations were revised. This study aimed to investigate the application status of initial inhalation therapy recommendations in patients with COPD and determine whether adherence to the GOLD …
Clinical characteristics and all-cause mortality in female patients with idiopathic pulmonary fibrosis in Chinese population
Background: Idiopathic pulmonary fibrosis (IPF) exhibits notable sex-based disparities and male patients with IPF are significantly more numerous than female patients. Therefore, the female patients are often overlooked and under-investigated. This study aimed to evaluate the clinical characteristics and all-cause mortality in female patients with IPF in Chinese population. Methods: /VA), laboratory analysis, comorbidities, and antifibrotic thera…
Chronic Obstructive Pulmonary Disease (COPD) Research (3 works) · Internal Medicine (3 works) · Medicine (3 works) · COPD (2 works) · Inhalation (2 works) · Inhalation and Respiratory Drug Delivery (2 works) · Anesthesia (1 work) · Area under the curve (1 work) · Asthma and respiratory diseases (1 work) · Biology (1 work)